Abstract:Selective degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease (PD) can be modeled by the administration of the neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)). Because abnormal mitochondrial dynamics are increasingly implicated in the pathogenesis of PD, in this study, we investigated the effect of MPP(+) on mitochondrial dynamics and assessed temporal and causal relationship with other toxic effects induced by MPP(+) in neuronal cells. In SH-SY5Y cells, MPP(+) causes a rapid increase in mitochondrial fragmentation followed by a second wave of increase in mitochondrial fragmentation, along with increased DLP1 expression and mitochondrial translocation. Genetic inactivation of DLP1 completely blocks MPP(+)-induced mitochondrial fragmentation. Notably, this approach partially rescues MPP(+)-induced decline in ATP levels and ATP/ADP ratio and increased [Ca(2+)](i) and almost completely prevents increased reactive oxygen species production, loss of mitochondrial membrane potential, enhanced autophagy and cell death, suggesting that mitochondria fragmentation is an upstream event that mediates MPP(+)-induced toxicity. On the other hand, thiol antioxidant N-acetylcysteine or glutamate receptor antagonist D-AP5 also partially alleviates MPP(+)-induced mitochondrial fragmentation, suggesting a vicious spiral of events contributes to MPP(+)-induced toxicity. We further validated our findings in primary rat midbrain dopaminergic neurons that 0.5 mu M MPP(+) induced mitochondrial fragmentation only in tyrosine hydroxylase (TH)-positive dopaminergic neurons in a similar pattern to that in SH-SY5Y cells but had no effects on these mitochondrial parameters in TH-negative neurons. Overall, these findings suggest that DLP1-dependent mitochondrial fragmentation plays a crucial role in mediating MPP(+)-induced mitochondria abnormalities and cellular dysfunction and may represent a novel therapeutic target for PD.

DNA polymerase-beta is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons.

DNA polymerase-β is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons

Proliferating Cell Nuclear Antigen Binds Dna Polymerase-Beta And Mediates 1-Methyl-4-Phenylpyridinium-Induced Neuronal Death

Gene Expression Profiling of MPP+-treated MN9D Cells: A Mechanism of Toxicity Study

2′,3′-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

Cell Cycle Regulation Of Dna Polymerase Beta In Rotenone-Based Parkinson'S Disease Models

Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.

Abnormal DNA Methylation in Substantia Nigra Region of MPTP-induced Mouse Model of Parkinson's Disease

Low concentrations of 1‐methyl‐4‐phenylpyridinium ion induce caspase‐mediated apoptosis in human SH‐SY5Y neuroblastoma cells

Poly(ADP-ribose) Polymerase Activation Mediates 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp)-Induced Parkinsonism

A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons.

DLP1-dependent Mitochondrial Fragmentation Mediates 1-Methyl-4-phenylpyridinium Toxicity in Neurons: Implications for Parkinson's Disease.

Nuclear factor-κB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum

Mitochondrial calcium uniporter-mediated inhibition of 1-methyl-4-phenylpyridinium ions neurotoxicity in PC12 cells

Tet1-mediated DNA Demethylation Regulates Neuronal Cell Death Induced by Oxidative Stress

Activation of C-Jun and Suppression of Phospho-P44/42 Were Involved in Diphenylhydantoin-Induced Apoptosis of Cultured Rat Cerebellar Granule Neurons.

Cdc25A phosphatase is activated and mediates neuronal cell death by PUMA via pRb/E2F1 pathway in a model of Parkinson's disease

Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells

NMDA but Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase

Deficiency of Trim27 Protects Dopaminergic Neurons from Apoptosis in the Neurotoxin Model of Parkinson׳s Disease

Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.